Biosimilars Conference 2014

Biosimilars 11th Annual Conference: Identify and execute a successful biosimilar development plan with technical case studies and practical advice from leading biosimilar and regulatory players

Key reasons not to miss Biosimilars 2014:
• Hospira and Egis Pharmaceuticals discuss the routes and launch strategy for the very first mAb biosimilar in Europe - how should you spend your resources?
• Discover the latest on EU positions for interchangeability and substitution and comparison with the FDA proposals
• Learn from Teva on how to carry out meaningful “fingerprint”-like analysis for effective biosimilar characterisation
• Benchmark your global clinical biosimilar trials – experience from Sandoz examples with TNFα inhibitors.
• Understand global development of biosimilars: with insight into Russia, CIS, Latin America and China

Speakers Include:
Dr. Gabriele Reichmann - Paul-Ehrlich-Institute

Paul Greenland Hospira - Biologics Hospira

Dr Virginia Acha - Amgen

Dr Karsten Roth Sandoz - Sandoz Biopharmaceutical Development

Peter Mazsar MD - Egis Pharmaceuticals

Henri Kornmann - Merck Serono

Fermin Ruiz de Erenchun - Roche

Daotian Fu Livzon - Mabpharm, Inc.
and many more...